INS and type 2 diabetes mellitus: Moreover, Angiopoietin-like 2, a circadian gene, improves T2DM through potentiation of insulin sensitivity in mice53, suggesting that our GO results imply possibility for the circadian genes to act as drug targets against T2DM.